Rising population of survivors of oral squamous cell cancer in the United States

Cancer

Volumn 122, Issue 9, 2016, Pages 1380-1387

  Patel, Mira A ^a   Blackford, Amanda L ^a   Rettig, Eleni M ^a   Richmon, Jeremy D ^a   Eisele, David W ^a   Fakhry, Carole ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

human papillomavirus; oral cancer; oropharyngeal cancer; survivors

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER SURVIVOR; CAUCASIAN; CAUSE SPECIFIC SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREND STUDY; UNITED STATES; AGED; BLACK PERSON; CANCER REGISTRY; CARCINOMA, SQUAMOUS CELL; ETHNOLOGY; INCIDENCE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; SEX RATIO; STATISTICS AND NUMERICAL DATA; SURVIVOR;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; CARCINOMA, SQUAMOUS CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDIES; SEER PROGRAM; SEX DISTRIBUTION; SURVIVORS; UNITED STATES;

EID: 84959898822     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29921     Document Type: Article

References (53)

1. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al., Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013; 31: 4550-4559.
2. Chaturvedi AK, Engels EA, Pfeiffer RM, et al., Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29: 4294-4301.
3. Gillison ML,. Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. J Clin Oncol. 2006; 24: 5623-5625.
4. Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM,. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg. 2001; 125: 1-9.
5. Fakhry C, Westra WH, Li S, et al., Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100: 261-269.
6. Weinberger PM, Yu Z, Haffty BG, et al., Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006; 24: 736-747.
7. Schlecht NF,. Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence. Oncol Rep. 2005; 14: 1239-1247.
8. Ritchie JM, Smith EM, Summersgill KF, et al., Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003; 104: 336-344.
9. Dahlgren L, Dahlstrand HM, Lindquist D, et al., Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer. 2004; 112: 1015-1019.
10. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP,. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005; 114: 806-816.
11. Bleyer A,. Cancer of the oral cavity and pharynx in young females: increasing incidence, role of human papilloma virus, and lack of survival improvement. Semin Oncol. 2009; 36: 451-459.
12. Toporcov TN, Znaor A, Zhang ZF, et al., Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium. Int J Epidemiol. 2015; 44: 169-185.
13. Li R, Faden DL, Fakhry C, et al., Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke. Head Neck. 2015; 37: 1642-1649.
14. Joseph LJ, Goodman M, Higgins K, et al., Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis. Oral Oncol. 2015; 51: 586-592.
15. Patel SC, Carpenter WR, Tyree S, et al., Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol. 2011; 29: 1488-1494.
16. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26: 612-619.
17. Pulte D, Brenner H,. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 2010; 15: 994-1001.
18. Hewitt M, Rowland JH, Yancik R,. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003; 58: 82-91.
19. Surveillance, Epidemiology, and End Results Program. SEER∗Stat Database: SEER 9 Regs Research Data, Nov. 2013 Sub (1973-2011) -Linked to County Attributes-Total US, 1969-2012 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2014, based on the November 2013 submission.
20. Surveillance, Epidemiology, and End Results Program. SEER∗Stat Database: SEER 18 Regs Research Data + Hurricane Katrina-Impacted Louisiana Cases, Nov. 2013 Sub (1973-2011 varying)-Linked to County Attributes-Total US, 1969-2012 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2014, based on the November 2013 submission.
21. Gillison ML, Koch WM, Capone RB, et al., Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92: 709-720.
22. D'Souza G, Kreimer AR, Viscidi R, et al., Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356: 1944-1956.
23. Surveillance Research Program, National Cancer Institute. SEER∗Stat software, version 8.2.1. seer.cancer.gov/seerstat. Accessed April 20, 2015.
24. Surveillance Research Program, National Cancer Institute. Limited duration prevalence. http://surveillance.cancer.gov/prevalence/limited.html. Accessed on May 8, 2015.
25. Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute. Joinpoint Regression Program, Version 4.2.0. Bethesda, MD: Statistical Methodology and Applications Branch, National Cancer Institute; 2015.
26. Kim HJ, Fay MP, Feuer EJ, Midthune DN,. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19: 335-351.
27. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2014.
28. Taibi R, Lleshi A, Barzan L, et al., Head and neck cancer survivors patients and late effects related to oncologic treatment: update of literature. Eur Rev Med Pharmacol Sci. 2014; 18: 1473-1481.
29. Maria Hewitt SG, Ellen Stovall, eds. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: Institute of Medicine and National Research Council of the National Academies; 2006.
30. Adelstein D, Ridge J, Gillison M, et al., Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck. 2009; 31: 1393-1422.
31. Adelstein DJ, Ridge JA, Brizel DM, et al., Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia. Head Neck. 2012; 34: 1681-1703.
32. Fakhry C, Andersen KK, Eisele DW, Gillison ML,. Oropharyngeal cancer survivorship in Denmark, 1977-2012. Oral Oncol. 2015; 51: 982-984.
33. Devesa SS, Blot WJ, Fraumeni JF Jr,. Cohort trends in mortality from oral, esophageal, and laryngeal cancers in the United States. Epidemiology. 1990; 1: 116-121.
34. Hoffstetter S, Marchal C, Peiffert D, et al., Treatment duration as a prognostic factor for local control and survival in epidermoid carcinomas of the tonsillar region treated by combined external beam irradiation and brachytherapy. Radiother Oncol. 1997; 45: 141-148.
35. Mroz EA, Forastiere AA, Rocco JW,. Implications of the oropharyngeal cancer epidemic. J Clin Oncol. 2011; 29: 4222-4223.
36. Kraaijenga SA, van der Molen L, Jacobi I, Hamming-Vrieze O, Hilgers FJ, van den Brekel MW,. Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises. Eur Arch Otorhinolaryngol. 2014; 272: 3521-3531.
37. Welsh LC, Dunlop AW, McGovern T, et al., Neurocognitive function after (chemo)-radiotherapy for head and neck cancer. Clin Oncol (R Coll Radiol). 2014; 26: 765-775.
38. Huber MA, Tantiwongkosi B,. Oral and oropharyngeal cancer. Med Clin North Am. 2014; 98: 1299-1321.
39. Fakhry C, Zhang Q, Nguyen-Tan PF, et al., Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol. 2014; 32: 3365-3373.
40. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM,. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001; 92: 805-813.
41. Jemal A, Simard EP, Dorell C, et al., Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013; 105: 175-201.
42. Colevas AD,. Population-based evaluation of incidence trends in oropharyngeal cancer focusing on socioeconomic status, sex, and race/ethnicity. Head Neck. 2014; 36: 34-42.
43. Simard EP, Ward EM, Siegel R, Jemal A,. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012; 62: 118-128.
44. Brown LM, Check DP, Devesa SS,. Oropharyngeal cancer incidence trends: diminishing racial disparities. Cancer Causes Control. 2011; 22: 753-763.
45. Mehta V, Yu GP, Schantz SP,. Population-based analysis of oral and oropharyngeal carcinoma: changing trends of histopathologic differentiation, survival and patient demographics. Laryngoscope. 2010; 120: 2203-2212.
46. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C,. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015; 33: 3235-3242.
47. Richter PA, Bishop EE, Wang J, Kaufmann R,. Trends in tobacco smoke exposure and blood lead levels among youths and adults in the United States: the National Health and Nutrition Examination Survey, 1999-2008. Prev Chronic Dis. 2013; 10: E213.
48. Jamal A, Agaku IT, O'Connor E, King BA, Kenemer JB, Neff L,. Current cigarette smoking among adults-United States, 2005-2013. MMWR Morb Mortal Wkly Rep. 2014; 63: 1108-1112.
49. Arrazola RA, Neff LJ, Kennedy SM, Holder-Hayes E, Jones CD,; Centers for Disease Control and Prevention (CDC). Tobacco use among middle and high school students-United States, 2013. MMWR Morb Mortal Wkly Rep. 2014; 63: 1021-1026.
50. King BA, Dube SR, Tynan MA,. Current tobacco use among adults in the United States: findings from the National Adult Tobacco Survey. Am J Public Health. 2012; 102: e93-e100.
51. Centers for Disease Control and Prevention. Quick stats: current smoking among men aged 25-64 years, by age group and veteran status-National Health Interview Survey (NHIS), United States, 2007-2010. MMWR Morbid Mortal Wkly Rep. 2012; 61:10. Article ID: 649498.
52. Settle K, Posner MR, Schumaker LM, et al., Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila). 2009; 2: 776-781.
53. Brown LM, Check DP, Devesa SS,. Oral cavity and pharynx cancer incidence trends by subsite in the United States: changing gender patterns. J Oncol. 2012; 2012: 649498.